Nomura Asset Management’s bluebird bio BLUE Stock Holding History

Nomura Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-154	Closed	-$236K	–	924
2018 Q3	$292K	Hold	154	–	–	﹤0.01%	884
2018 Q2	$314K	Sell	154 -320	-68%	-$729K	﹤0.01%	884
2018 Q1	$1.05M	Buy	474 +320	+208%	+$814K	0.01%	729
2017 Q4	$356K	Buy	+154	New	+$313K	﹤0.01%	857

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Asset Management's BLUE Position: Q4 2018 in Review

Nomura Asset Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 154 shares — an estimated $236K sold.

Nomura Asset Management first reported a position in BLUE in Q4 2017 and held it in 4 quarters. The position peaked at $1.05M in Q1 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Nomura Asset Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Nomura Asset Management sold 154 bluebird bio shares in Q4 2018, an estimated $236K.
Nomura Asset Management first reported a position in bluebird bio in Q4 2017 and held it in 4 quarters.
Nomura Asset Management's bluebird bio position peaked at $1.05M in Q1 2018.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Nomura Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.